Pfizer's lung cancer combination therapy approved by the FDA
Pfizer Inc (NYSE:PFE) announced that the United States Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) plus MEKTOVI (binimetinib) for adult patients with metastatic non-small...
FDA approves Pfizer's Braftovi plus Mektovi for a type of non-small cell lung cancer
Pfizer Inc. PFE, -0.18% said Thursday the U.S. Food and Drug Administration has approved its Braftovi plus Mektovi combination therapy as a treatment for patients with metastatic non-small cell lun...
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot- Care Access
The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer and French partner Valneva's trial of a Lyme disease vaccine candidate, the contract resear...
Dividend Alert: Buy Pfizer Stock Before This Date!
In 2023, a year when the market has heavily favored technology stocks, drugmakers like Pfizer (NYSE: PFE ) seem to have been left behind. However, if PFE stock is trading at a low price and Pfizer ...
Pfizer (PFE) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Pfizer (PFE) concluded the recent trading session at $33.20, signifying a +0.21% move from its prior day's close.
Nobel for mRNA: Which other biotech stocks might be overlooked?
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v...
Dividend Paying Stocks To Buy In October 2023? 2 In Focus
Dividend paying stocks to check out in the stock market today.
Final Trades: Rivian, Pfizer, Treasury Bonds and more
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Where Will Pfizer Be in 5 Years?
Its business is slowing because COVID-19 revenue has fallen drastically this year. The company is also facing the loss of patent protection on multiple drugs.
Pfizer Inc. (PFE) Cantor Fitzgerald Annual Global Health Conference (Transcript)
Pfizer Inc. (NYSE:PFE ) Cantor Fitzgerald Annual Global Health Conference Call September 26, 2023 3:30 PM ET Company Participants Albert Bourla - Chairman & CEO Conference Call Participants Louise ...
About 250,000 courses of COVID pill Paxlovid being administered per week - Pfizer CEO
Pfizer Inc's chief executive said on Tuesday that almost 250,000 courses of the drugmaker's oral antiviral COVID-19 treatment Paxlovid were being administered per week as cases surged in the United...
Pfizer restarts production at tornado-damaged facility, but some supply is still affected
Pfizer Inc. said late Monday that it has restarted production at a North Carolina facility badly damaged by a tornado in July, but warned that some medications will not be in “full supply” until ne...
Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected
Pfizer expects operations to fully resume by the end of the year, but it warned that supply of some medicines would be affected until at least mid-2024.
Pfizer restarts production at tornado-hit North Carolina plant
Pfizer said on Monday it has restarted majority of the production lines at its tornado-hit North Carolina plant, but warned that supply of some drugs from the facility may not be fully restored unt...
CDC Recommends Pfizer's (PFE) RSV Jab to Protect Newborns
Pfizer's (PFE) Abrysvo has been recommended by the CDC for preventing RSV in infants by immunizing pregnant women, during weeks 32-36 of pregnancy.
Related Companies